Comparison between CT Scan Evaluation Criteria and PERCIST for Evaluation of Immune Check-Point Inhibitors Response

被引：0
|
作者：
Rossi, Giovanni [1 ]
Genova, Carlo [1 ]
Morbelli, Silvia [2 ]
Rijavec, Erka [1 ]
Barletta, Giulia [1 ]
Biello, Federica [1 ]
Maggioni, Claudia [1 ]
Mennella, Simone [3 ]
Dal Bello, Maria Giovanna [1 ]
Distefano, Roberta [1 ]
Bauckneht, Matteo [2 ]
Cittadini, Giuseppe [3 ]
Merlo, Franco [1 ]
Sambuceti, Gianmario [2 ]
Grossi, Francesco [1 ]
机构：
[1] San Martino Hosp, Natl Inst Canc Res, Lung Canc Unit, Genoa, Italy
[2] San Martino Hosp, Natl Inst Canc Res, Nucl Med, Genoa, Italy
[3] San Martino Hosp, Natl Inst Canc Res, Radiol, Genoa, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
response evaluation; Nivolumab; PERCIST; RECIST;
D O I：
10.1016/j.jtho.2016.11.458
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA10.09
引用
收藏
页码：S401 / S402
页数：2
相关论文
共 50 条
  • [21] Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: cui bono?
    Hernaez, Ruben
    Avila, Matias A.
    GUT, 2023, 72 (01) : 7 - 9
  • [22] Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumours of lung (LCNET)
    Sherman, S.
    Rotem, O.
    Zer, A.
    Shochat, T.
    Dudnik, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [23] Evaluation of treatment response in lymphoma with PET Response Criteria in Solid Tumors (PERCIST): Comparison to visual results of Revised Response Criteria (RRC)
    Tatsumi, Mitsuaki
    Isohashi, Kayako
    Watabe, Tadashi
    Kato, Hiroki
    Shimosegawa, Eku
    Hatazawa, Jun
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [24] Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
    Oroujeni, Maryam
    Bezverkhniaia, Ekaterina A.
    Xu, Tianqi
    Liu, Yongsheng
    Plotnikov, Evgenii, V
    Karlberg, Ida
    Ryer, Eva
    Orlova, Anna
    Tolmachev, Vladimir
    Frejd, Fredrik Y.
    PHARMACEUTICS, 2022, 14 (09)
  • [25] Therapy response evaluation with FDG-PET/CT in small cell lung cancer: a prognostic and comparison study of the PERCIST and EORTC criteria
    Ziai, D.
    Wagner, T.
    El Badaoui, A.
    Hitzel, A.
    Woillard, J. B.
    Melloni, B.
    Monteil, J.
    CANCER IMAGING, 2013, 13 (01) : 73 - 80
  • [26] Comparison of RECIST, EORTC criteria and PERCIST using MRI and PET/CT for evaluation of early response of neoadjuvant chemotherapy in patients with cervical carcinoma
    Sun, Yanqin
    Yu, Lijuan
    Nanding, Abiyasi
    Wang, Wenzhi
    Kuai, Zi-Xiang
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [27] Comparison of RECIST, EORTC criteria and PERCIST using MRI and PET/CT for evaluation of early response of neoadjuvant chemotherapy in patients with cervical carcinoma
    Sun, Yanqin
    Yu, Lijuan
    Nanding, Abiyasi
    Wang, Wenzhi
    Kuai, Zi-Xiang
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [28] Evaluation of Affibody-Based Binder for Targeting of Immune Check-Point Molecule B7-H3
    Oroujeni, M.
    Bezverkhniaia, E.
    Xu, T.
    Liu, Y.
    Plotnikov, E.
    Karlberg, I.
    Orlova, A.
    Tolmachev, V.
    Frejd, F. Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S280 - S280
  • [29] Comparison of PET Response Criteria in Solid Tumors (PERCIST) and Response Evaluation Criteria in Solid Tumors (RECIST) in neoadjuvant chemotherapy for esophageal cancer
    Yanagawa, Masahiro
    Tatsumi, Mitsuaki
    Morii, Eiichi
    Watabe, Tadashi
    Isohashi, Kayako
    Kato, Hiroki
    Okusu, Ikuko
    Shimosegawa, Eku
    Tomiyama, Noriyuki
    Hatazawa, Jun
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [30] Evaluation of Affinity Matured Affibody Molecules for Imaging of Immune Check-Point Protein B7-H3
    Oroujeni, M.
    Bezverkhniaia, E.
    Xu, T.
    Liu, Y.
    Plotnikov, E.
    Ryer, E.
    Karlberg, I.
    Orlova, A.
    Frejd, F.
    Tolmachev, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S319 - S319
12345